Continuous Therapy With Certolizumab Pegol Maintains Remission of Patients With Crohn's Disease for up to 18 Months

G.R. Lichtenstein, O.O. Thomsen, S. Schreiber, Ian Lawrance, S.B. Hanauer, R. Bloomfield, W.J. Sandborn

    Research output: Contribution to journalArticle

    85 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)600-609
    JournalClinical Gastroenterology and Hepatology
    Issue number7
    Publication statusPublished - 2010

    Cite this